GALAPAGOS Aktie

 >GALAPAGOS Aktienkurs 
107.70 EUR    +3.0%    (Tradegate)
Ask: 107.90 EUR / 50 Stück
Bid: 107.75 EUR / 50 Stück
Tagesumsatz: 399 Stück
Realtime Kurs von 8 bis 22 Uhr!
>GALAPAGOS Performance
1 Woche: -1,4%
1 Monat: -9,1%
3 Monate: -38,5%
6 Monate: -45,4%
1 Jahr: -23,3%
laufendes Jahr: -42,6%
>GALAPAGOS Aktie
Name:  GALAPAGOS N.V.
Land:  Belgien
Sektor:  Gesundheit
ISIN/ Wkn:  BE0003818359 / A0EAT9
Symbol/ Ticker:  GXE (Frankfurt)
Kürzel:  FRA:GXE, GXE.F, GXE:GR
Index:  AEX
Webseite:  http://www.glpg.com/
Marktkapitalisierung:  6780 Mio. EUR
Umsatz:  1010 Mio. EUR
EBITDA:  345.95 Mio. EUR
Gewinn je Aktie:  1.22 EUR
Schulden:  27.26 Mio. EUR
Liquide Mittel:  5570 Mio. EUR
Umsatz-/ Gewinnwachstum:  74.10% / -
KGV/ KGV lG:  59.85 / -
KUV/ KBV/ PEG:  6.96 / 2.4 / -
Gewinnm./ Eigenkapitalr.:  7.92% / 4.09%
Dividende je Aktie:  -
Dividendenrendite/ -schätzung:  - / -
Suchwörter:  GALAPAGOS
Letzte Datenerhebung:  23.10.20
>GALAPAGOS Eigentümer
Aktien: 65.34 Mio. St.
f.h. Aktien: 41.88 Mio. St.
Insider Eigner: 25.78%
Instit. Eigner: 41.63%
Leerverk. Aktien: -
>GALAPAGOS Peer Group

UCB
 
24.10.20 - 00:01
 Galapagos Is A Buy Despite Setback In The U.S. (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
21.10.20 - 21:31
 Galapagos -6.8% on downgrade by Goldman Sachs (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
18.10.20 - 12:22
 Galapagos Knee Osteoarthritis Data, And Other News: The Good, Bad And Ugly Of Biopharma (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
16.10.20 - 13:28
 The Daily Biotech Pulse: Amarin Vascepa Data, Galapagos Osteoarthritis Drug Update, 4 IPOs (Benzinga)
 
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 15) read more...
16.10.20 - 13:13
 Boeing, Galapagos, Intuitive Surgical: What to Watch When the Stock Market Opens Today (WSJ EN)
 
The S&P 500 is on track for this year's most tepid weekly gain, with rising coronavirus cases and dimming stimulus prospects weighing on sentiment....
16.10.20 - 08:46
 SNY/TBIO Move COVID-19 Vaccine Into Clinic, AVXL′s PDD Study Promising, EIGR On Watch (RTTNews)
 
Today's Daily Dose brings you news about Eiger BioPharma's COVID-19 ILIAD study results, disappointing results of Servier/Galapagos' knee osteoarthritis drug trial, Anavex Life's Parkinson's disease dementia trial, the progress in Sanofi/Transla...
16.10.20 - 04:49
 Galapagos knee osteoarthritis trial fails to meet goals (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
15.10.20 - 22:21
 Galapagos and Servier report topline results for ROCCELLA Phase 2 clinical trial with GLPG1972/S201086 in knee osteoarthritis patients (GlobeNewswire EN)
 
Mechelen, Belgium and Paris, France, 15 OCTOBER 2020, 22.01 CET; regulated information –Servier and Galapagos NV (Euronext & NASDAQ: GLPG) report that no signal of activity was observed in the topline results in their ROCCELLA Phase 2 trial with GL...
13.10.20 - 22:19
 Gilead & Galapagos Announce Positive Data on UC Candidate (Zacks)
 
Gilead (GILD) and partner Galapagos report positive data on filgotinib for the indication of active ulcerative colitis....
13.10.20 - 16:16
 ATXI Plunges On Thumbs-down, VYGR′s Huntington′s Disease Trial On Hold, Deal Or No Deal For SURF? (RTTNews)
 
Today's Daily Dose brings you news about FDA declining approval for Avenue Therapeutics/Fortress Biotech's pain drug IV Tramadol, encouraging data from Gilead/ Galapagos' Ulcerative Colitis trial, reports of Surface Oncology receiving a takeover o...
13.10.20 - 08:01
 ATXI Plunges On Thumbs-down, VYGR′s Huntington′s Disease Trial On Hold, Deal Or No Deal For SURF? (RTTNews)
 
Today's Daily Dose brings you news about FDA declining approval for Avenue Therapeutics/Fortress Biotech's pain drug IV Tramadol, encouraging data from Gilead/ Galapagos' Ulcerative Colitis trial, reports of Surface Oncology receiving a takeover o...
12.10.20 - 16:34
 Gilead and Galapagos′s filgotinib shows sustained efficacy in ulcerative colitis study (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
12.10.20 - 09:07
 e-therapeutics re-energised as executive chairman Mortazavi takes over CEO duties (Proactive Investors)
 
e-therapeutics PLC (LON:ETX) said in its interim results statement it remains in active discussions with large pharmaceutical and biotechnology companies about future collaborations. Meanwhile, its recently announced collaboration with Galapagos is o...
01.10.20 - 21:04
 Galapagos Begins Dosing With GLPG3970 in Psoriasis Study (Zacks)
 
Galapagos (GLPG) doses the first patient in an early-stage study on its Toledo compound GLPG3970 for treating psoriasis. The same is also being studied for ulcerative colitis and rheumatoid arthritis....
30.09.20 - 12:55
 Dosing underway in Galapagos psoriasis trial (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
29.09.20 - 22:06
 Galapagos announces first dosing with Toledo compound GLPG3970 in psoriasis trial (GlobeNewswire EN)
 
Mechelen, Belgium; 29 September 2020, 22.01 CET – Galapagos NV (Euronext & NASDAQ: GLPG) announces dosing of a first patient in their psoriasis trial, one of three patient trials currently recruiting to evaluate efficacy and safety of Toledo compou...
28.09.20 - 21:49
 Gilead & Galapagos′ RA Drug Receives Approval in Europe (Zacks)
 
Gilead (GILD) and partner Galapagos win approval for their rheumatoid arthritis (RA) drug in Europe....
28.09.20 - 16:34
 Galapagos Gets First Commercial Drug With Jyseleca Approval (Zacks)
 
Galapagos (GLPG) and Gilead announce approval of Jyseleca in Europe as a treatment for rheumatoid arthritis patients....
25.09.20 - 20:07
 Galapagos ADR (GLPG) Investor Presentation - Slideshow (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
25.09.20 - 19:22
 Gilead and Galapagos′ filgotinib OK′d in Europe for rheumatoid arthritis (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
>Zitat des Tages: Sitze nicht, wo die Spötter sitzen, denn sie sind die elendesten unter allen Kreaturen. - Matthias Claudius
Partner:    >Tradegate Börse | >TraderFox Handelssignale | >Heibel-Ticker Börsenbrief | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf Twitter

Copyright @ Boersentreff.de - Die Märkte im Blick!